Anthropic IPO Prices at $1T Value, Half Its $2T Peak Talk
AiX — Free Expert Advisor
Trades XAUUSD on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. AiX is informational software — not investment advice. Past performance does not guarantee future results.
Anthropic is set to list on Nasdaq next week at a valuation of around $1 trillion, well below the $2 trillion figure some on Wall Street had discussed before a run of AI-led selloffs hit technology stocks. The Claude maker plans to sell 825 million shares at $70 to $78 each, pricing on 18 November with trading under ticker ANT from 19 November. At the midpoint the offering raises about $61 billion. Strategic investors will buy roughly $26 billion more at the IPO price.
Context — Why the Anthropic IPO Matters Now
The gap between the $1 trillion target and the $2 trillion once floated is the story. Anthropic is coming to market at about half the valuation once talked about, and that reset lands after AI-linked names sold off. Microsoft traded at $523.00, down 1.91% on the day, as of 23:25 UTC today. Nvidia was at $166.19, down 1.60%. Alphabet bucked the move at $298.70, up 3.94%.
The report frames the listing as a direct test of AI risk appetite. Strong demand would suggest investors still see value in leading AI names at lower valuations. A weak debut would likely weigh on the wider AI infrastructure trade.
The catalyst chain runs through the selloff. Anthropic had been the subject of far larger valuation talk before technology stocks fell, and the company is now pricing into that weaker backdrop rather than ahead of it. The earlier headlines support the point: Anthropic reserved up to 20% of its $64 billion IPO for retail investors, and the deal was reported as oversubscribed several times ahead of what was described as a record $90 billion listing.
What changed is arithmetic. A $1 trillion entry price is easier to clear than $2 trillion, and the company brings a large cash pile against heavy compute commitments. The listing also pulls roughly $87 billion out of the market between the public offering and the strategic placement, money that could otherwise sit in other tech holdings in the run-up to pricing.
Data — What the Numbers Show
Third-quarter revenue rose more than 12-fold from a year earlier to about $17 billion. October sales reached an annualised run rate of around $80 billion. The company reported an adjusted operating margin of 15% in the quarter, against an operating loss a year earlier, and targets 35% over the long term.
At the midpoint, with about 13.1 billion shares outstanding, the valuation lands near $1 trillion, or about $1.2 trillion fully diluted. That is roughly 12 to 13 times October's annualised sales.
| Item | Figure |
|---|---|
| Shares offered | 825 million |
| Price range | $70 to $78 |
| Midpoint raise | About $61 billion |
| Strategic placement | About $26 billion |
| Post-IPO cash | Around $210 billion |
Cash stands at about $132 billion with no conventional debt, expected to rise to around $210 billion after the offering. Against that sit about $900 billion of compute commitments through 2045, including $29 billion due in 2027.
The headline GAAP figures need context. As Anthropic's private valuation rose, so did the value of convertible securities issued to early investors, and accounting rules treat that increase as a loss. That noncash charge came to about $94 billion over the first nine months of 2026, and the company strips it out of adjusted results. The convertibles convert to common stock at the IPO.
Analysis — What It Means for AI Tickers
Second-order effects run through the strategic investor list. Microsoft, Nvidia, Alphabet and Micron Technology are tied to the deal through the roughly $26 billion placement, so a strong debut supports the wider AI infrastructure trade and a weak one weighs on it. Alphabet's 3.94% gain to $298.70 stands out against Microsoft's 1.91% decline and Nvidia's 1.60% drop, a split that shows the market is not treating every AI name alike.
The competitive risk is real. Rivals include OpenAI, Alphabet, Meta and, in particular, lower-cost open-weight models from China. Whether Anthropic can keep growing fast enough to cover its compute commitments and reach the 35% margin target is the question the market starts pricing next week.
A counter-argument deserves weight. The 15% adjusted operating margin is already positive against a prior-year loss, and the revenue base is expanding fast enough that the sales multiple would shrink quickly if growth holds. The $94 billion noncash charge is a valuation artifact, not cash leaving the business.
Positioning is split. Retail investors have up to 20% of the shares set aside, sold through the main underwriting group led by Goldman Sachs and Morgan Stanley, and through brokers including Robinhood, Charles Schwab and Fidelity. Reports say the deal is heavily oversubscribed, so many retail buyers may get small allocations or none at all. Institutional demand for the strategic placement is the other side of that flow.
Outlook — What to Watch Next
Pricing lands on 18 November, with Nasdaq trading in ANT starting 19 November. Those are the two dates that matter. Before then, the bookbuild decides whether the deal clears the top of the $70 to $78 range or settles lower.
Watch the strategic investors on debut. Microsoft, Nvidia, Alphabet and Micron all carry exposure through the placement, and their share moves around pricing will show whether the market reads the listing as a validation of AI infrastructure spending or as a competitor taking capital out of the sector.
Watch the $29 billion of compute commitments due in 2027 against the roughly $210 billion post-IPO cash position. If revenue keeps compounding from the $80 billion annualised October run rate, that coverage looks comfortable. If growth slows, the margin path to 35% gets harder, and the stock will price that before the financials do.
Frequently Asked Questions
How much of the Anthropic IPO is reserved for retail investors?
Up to 20% of the shares are set aside for individuals. They are sold through the main underwriting group, led by Goldman Sachs and Morgan Stanley, and through retail brokers including Robinhood, Charles Schwab and Fidelity. Reports say the deal is heavily oversubscribed, so many retail buyers may receive small allocations or none at all. The strategic placement of about $26 billion sits separately from that retail tranche.
Why is Anthropic's valuation half of what was once discussed?
Before a run of AI-led selloffs hit technology stocks, some on Wall Street had talked about a $2 trillion valuation. The company is now targeting around $1 trillion at the midpoint, or about $1.2 trillion fully diluted. The reset reflects the weaker backdrop rather than a change in the revenue trajectory, which showed third-quarter sales up more than 12-fold to about $17 billion.
What are Anthropic's biggest risks after listing?
Competition and spending commitments. Rivals include OpenAI, Alphabet, Meta and lower-cost open-weight models from China. The company has signed about $900 billion of computing commitments through 2045, including $29 billion due in 2027, against roughly $210 billion of expected post-IPO cash. Reaching the 35% long-term margin target depends on growth continuing fast enough to cover those costs.
Bottom Line
Anthropic's $1 trillion listing tests whether AI risk appetite survives the selloff at half the old valuation.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Trade XAUUSD on autopilot — free Expert Advisor
AiX is our free MetaTrader 5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. XAUUSD breakout engine.
PartnerPosition yourself for the macro moves discussed above
Start TradingSponsored
Ready to trade the markets?
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.